Journament

Keyword Connections - disease progression Keywords

Connection Type	Connection
Journals	No Journal Connected
Research Groups	No Research Group Connected
Bibliographies	[1] Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index [2] Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins [3] Safety and efficacy following 10-years of overnight orthokeratology for myopia control [4] Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis [5] Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey [6] Dietary restriction and glucose regulation in aging rhesus monkeys: a follow-up report at 8.5 yr [7] Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis [8] Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery [9] Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study [10] CD4 and total lymphocyte counts as predictors of HIV disease progression [11] The role of HSV in the transmission and progression of HIV [12] Effect of spectacle lenses designed to reduce relative peripheral hyperopia on myopia progression in Japanese children: a 2-year multicenter randomized controlled trial [13] Use of total lymphocyte count for monitoring response to antiretroviral therapy [14] Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States [15] Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes [16] Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis [17] An Antibody Designed to Improve Adoptive NK-Cell Therapy Inhibits Pancreatic Cancer Progression in a Murine Model [18] Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group [19] Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy [20] Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy [21] Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants Transmission Study Group [22] Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets [23] Clonal dominance patterns of CD8 T cells in relation to disease progression in HIV-infected children [24] Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life [25] Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD [26] Induction of specific T-cell responses in HIV infection [27] Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor [28] Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis [29] Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis [30] Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group [31] Distal tibial tubercle osteotomy is superior to the proximal one for progression of patellofemoral osteoarthritis in medial opening wedge high tibial osteotomy [32] Gingival inflammation and subgingival calculus as determinants of disease progression in early-onset periodontitis [33] Early and tight glycaemic control - the key to managing type 2 diabetes [34] Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial [35] The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes [36] Distal tuberosity osteotomy in open-wedge high tibial osteotomy does not exacerbate patellofemoral osteoarthritis on arthroscopic evaluation [37] PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer [38] Gingivitis as a risk factor in periodontal disease [39] Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression. [40] Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm. [41] Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiative—a prospective cohort study [42] [Enhancing monitoring of disease progression-remote sensoring in multiple sclerosis]. [43] A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy. [44] Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer's disease. [45] Neuropsychiatric Correlates of Small Vessel Disease Progression in Incident Cognitive Decline: Independent and Interactive Effects. [46] Scores of Health-Related Quality of Life Questionnaire Worsen Consistently in Patients of COPD: Estimating Disease Progression over 30 Years by SReFT with Individual Data Collected in SUMMIT Trial [47] CD4 and total lymphocyte counts as predictors of HIV disease progression [48] CD4 and total lymphocyte counts as predictors of HIV disease progression [49] new insights about treg and th17 cells in hiv infection and disease progression [50] age and environment influences on mouse prion disease progression: behavioral changes and morphometry and stereology of hippocampal astrocytes [51] change in content of multiple cytokines in the serum of mods mice and its relationship with disease progression [52] cellular transplantation alters the disease progression in becker’s muscular dystrophy [53] parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effects [54] a pilot trial of pioglitazone hcl and tretinoin in als: cerebrospinal fluid biomarkers to monitor drug efficacy and predict rate of disease progression [55] circadian rhythm dysfunction accelerates disease progression in a mouse model with amyotrophic lateral sclerosis [56] interstitial fluid flow in cancer: implications for disease progression and treatment [57] association between angiogenesis soluble factors and disease progression markers in chronic hepatitis c patients asociación entre factores angiogénicos solubles y marcadores de progresión de la enfermedad en pacientes con hepatitis crónica c [58] rapid disease progression of liver metastases following resection in a liver-transplanted patient with probable lynch syndrome – a case report and review of the literature [59] the angiogenic activity of ascites in the course of ovarian cancer as a marker of disease progression [60] changes in b-cell counts and percentages during primary hiv infection associated with disease progression in hiv-infected men who have sex with men: a preliminary study [61] blood transcriptional signatures for disease progression in a rat model of osteoarthritis [62] non-monotonic reorganization of brain networks with alzheimer’s disease progression [63] extracellular vesicles as modulators of tumor microenvironment and disease progression in glioma [64] etiology and pediatric chronic kidney disease progression: taiwan pediatric renal collaborative study [65] Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group [66] Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets [67] Clonal dominance patterns of CD8 T cells in relation to disease progression in HIV-infected children [68] Micronutrients and Human Immunodeficiency Virus Type 1 Disease Progression among Adults and Children [69] Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? [70] Gingival inflammation and subgingival calculus as determinants of disease progression in early-onset periodontitis [71] A Convolutional Neural Network Approach to Quantify Lung Disease Progression in Patients with Fibrotic Hypersensitivity Pneumonitis (HP). [72] Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis. [73] Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy [74] Endotoxin Activity Assay as a Novel Predictor of Disease Progression in Patients With Mild Cholangitis.